Optimization of the Fermentation and Preparation of the Wettable Powder Formulation of Bacillus velezensis F0b

被引:0
|
作者
Wen, Jiaqi [1 ]
Pi, Nana [1 ]
He, Fengting [1 ]
Zeng, Yuhao [1 ]
Weng, Qunfang [1 ,2 ]
Luo, Jianjun [1 ]
机构
[1] South China Agr Univ, Coll Plant Protect, Guangzhou 510642, Peoples R China
[2] Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Peoples R China
关键词
Bacillus velezensis; formulation; biopesticides; wettable powder; BOTRYTIS-CINEREA; BIOCONTROL; RESISTANCE; SUBTILIS;
D O I
10.3390/microorganisms13030560
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacillus velezensis is an effective biocontrol bacterium, with its microbial pesticides showing promise in biological control. In this study, we optimized the medium and conditions for fermenting strain F0b, developed a wettable powder formulation, and assessed its efficacy against Botrytis cinerea. We screened carriers, wetting agents, dispersants, and UV protectants compatible with F0b, determining the optimal ratio and dosage. The best medium for F0b fermentation included rice flour (3.472%), ammonium chloride (4.898%), and disodium phosphate (1.871%). The ideal fermentation conditions were a 20% inoculum volume, 40 degrees C temperature, 80% sterile water, and a 72 h fermentation time, yielding a viable count of 1.33 x 1010 CFU/mL. The final formulation contained 54.7% Bacillus velezensis dried powder, 27.3% kaolinite carrier, 16% wetting agent (3:7 ratio of sodium dodecyl sulfate to sodium lignin sulfonate), and 2% ascorbic acid as a UV protectant. All quality indicators met national standards, with a viable bacteria concentration of 7 billion CFU/g. Field trials showed that the F0b wettable powder effectively controlled Botrytis cinerea, with a disease index significantly lower than the control group. Control efficacy ranged from 50.58% to 73.14% over 7 to 14 days, demonstrating the commercial potential of this formulation.
引用
收藏
页数:18
相关论文
共 31 条
  • [31] Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma
    Korani, Mitra
    Ghaffari, Solmaz
    Attar, Hossein
    Mashreghi, Mohammad
    Jaafari, Mahmoud Reza
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 20